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The state of areflexia and muscle weakness that immediately follows a spinal cord injury
(SCI) is gradually replaced by the recovery of neuronal and network excitability, leading to
both improvements in residual motor function and the development of spasticity. In this
review we summarize recent animal and human studies that describe how motoneurons
and their activation by sensory pathways become hyperexcitable to compensate for the
reduction of functional activation of the spinal cord and the eventual impact on the
muscle. Specifically, decreases in the inhibitory control of sensory transmission and
increases in intrinsic motoneuron excitability are described. We present the idea that
replacing lost patterned activation of the spinal cord by activating synaptic inputs via
assisted movements, pharmacology or electrical stimulation may help to recover lost
spinal inhibition. This may lead to a reduction of uncontrolled activation of the spinal
cord and thus, improve its controlled activation by synaptic inputs to ultimately normalize
circuit function. Increasing the excitation of the spinal cord with spared descending and/or
peripheral inputs by facilitating movement, instead of suppressing it pharmacologically,
may provide the best avenue to improve residual motor function and manage spasticity
after SCI.
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INTRODUCTION
In the months following a spinal cord injury (SCI), 70–80% of
individuals develop spasticity (Maynard et al., 1990; Skold et al.,
1999), which is characterized by involuntary muscle activity such
as spasms, hyperreflexia, clonus and co-contraction (Pandyan
et al., 2005; Nielsen et al., 2007). There is also an increased resis-
tance to passive stretch and the development of joint contractures,
the latter characterized by reduced joint range of motion and
deformity mediated, in part, by changes to tissues in the muscle
and joint (Diong et al., 2012). Although spasticity can interfere
with residual motor function and produce pain, it can also be
useful. For example, involuntary muscle spasms (i.e., prolonged
contractions) and tone in extensor muscles can facilitate walking
(Skold, 2000), standing and transfers (Satkunam, 2003; Adams
and Hicks, 2005). In this review, we compare evidence from both
animal and human studies to discuss howmuscle and non-muscle
tissues respond to the different phases of SCI and how neurons
and neuronal circuits increase their excitability and decrease their
inhibitory capacity to compensate for the loss of descending and
movement-related sensory inputs, ultimately leading to the devel-
opment of spasticity. In many cases, there is good agreement with
animal and human studies but also some important differences.
We propose that instead of further suppressing spinal cord activ-
ity with antispastic medications, perhaps we should be doing just
the opposite, by finding ways to functionally reactivate the spinal
cord to restore lost inhibition and normalize neuronal and cir-
cuit function. In this way, improvements in both residual motor
control and/or reductions in spasticity can occur without the
unwanted side effects of antispastic medications.
ASSESSMENTS OF SPASTICITY IN HUMANS
Throughout this review, several clinical measures of spasticity are
discussed as they are used to evaluate the effectiveness of different
interventions (Hsieh et al., 2008). The frequently used Ashworth
(Ashworth, 1964) andmodified Ashworth (Bohannon and Smith,
1987) scales rate, from 0 to 4, the resistance of a relaxed, sin-
gle joint to movement imposed by the evaluator throughout
its full available range. The pendulum test, which also mea-
sures resistance to passive motion, records changes in knee joint
angle after the relaxed leg is allowed to swing freely following
its release from an extended position (Wartenberg, 1951; Bajd
and Vodovnik, 1984). To measure spasticity evoked by various
stimuli, the Spinal Cord Assessment Tool for Spasticity (SCATS)
rates, on a scale of 0–3, the severity of low frequency (4–12Hz)
rhythmic movements of the ankle (i.e., clonus, Wallace et al.,
2005) and flexor and extensor spasms in response to pinprick
or rapid leg extension, respectively (Benz et al., 2005). The self-
reported Penn spasm frequency scale asks patients to assess the
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average frequency and source of spasms from 0 (no spasms on
most days) to 4 (>10 spontaneous spasms/hour) (Penn et al.,
1989). However, like most of the other assessment methods, the
scale is ordinal with incompletely explored reliability, validity,
and responsiveness (Biering-Sorensen et al., 2006; Hsieh et al.,
2008). Moreover, these assessments are limited to a single point
in time during the assessment, even though spasticity varies by
time of day, recent activity level, temperature and emotional sta-
tus (Biering-Sorensen et al., 2006). Thus, more objectivemeasures
of spasticity, based on actual muscle activation patterns recorded
over many hours/days, are needed.
CHANGES IN TISSUE PROPERTIES AFTER SCI
MUSCLE
As with neurons and neuronal circuits, muscle and connective tis-
sue also adapt to SCI. With a reduced activity and unloading after
SCI in humans, muscles begin to atrophy within the first months
as measured by decreased fiber diameter, cross-sectional area and
volume (Scelsi et al., 1982; Lotta et al., 1991; Biering-Sorensen
et al., 2009). There are also changes in the joint angle-torque
relationship of some muscles that may accompany reductions in
the range of joint motion. For example, in plantarflexors (but
not dorsiflexors) peak twitch torque occurs at more plantarflexed
joint angles in SCI participants compared to non-injured controls
(McDonald et al., 2005; Pelletier and Hicks, 2010). The shift in
the joint angle-torque relationship has been attributed to short-
ening of the muscle as a result of sarcomere loss and increases in
connective tissue, but this has not been directly proven. Changes
in the composition of the muscle fiber can also occur after SCI,
although different results have been obtained when examining
non-spastic vs. spastic muscles. Several animal models of SCI,
where no clear spasticity develops, and several human studies
have a reported a decrease in the proportion of the fatigue-
resistant type I and less-fatigable type IIa fibers coupled with an
increase in the most-fatigable type IIb or IId/x fibers [abbrevi-
ated together as IIb(x)](Scelsi et al., 1982; Lotta et al., 1991; Roy
et al., 1992, 1999; Harris et al., 2007; Malisoux et al., 2007). In
humans with complete SCI, the slower-to-faster fiber type tran-
sitions begin ∼4–7 months post-SCI and continue until almost
all fibers are type IIb(x), which can occur 2–6 years post-SCI
(reviewed in Biering-Sorensen et al., 2009).
Importantly, in the studies described above, the amount of
muscle activity present from day-to-day was not well described. It
is reasonable to assume that muscle activity has an effect on skele-
tal muscle properties. As a model of this, acute transection of the
sacral spinal cord in adult rats initially results in tail muscles that
are inactive, but then a clear spasticity syndrome develops 2 weeks
later that mimics what happens after SCI in humans (Bennett
et al., 1999, 2004). Acutely, when muscles of the tail were inac-
tive, as measured by 24-h EMG recordings, there was a transition
from slow, fatigue-resistant type I to predominantly fast, fatigable
type IIb(x) fibers compared to uninjured control animals (Harris
et al., 2007). However, in spastic muscles with enhanced EMG
activity compared to controls, the amount of atrophy measured
in the myofibers was substantially reduced. Moreover, the pro-
portion of type I to type II fibers was similar to age-matched
control rats (Harris et al., 2007), although the muscles were
more fatigable (Harris et al., 2006). In agreement with the rat
results, participants with motor incomplete [ASIA Impairment
Scale (AIS) C&D] or motor complete (AIS A&B) injuries having
marked spasticity exhibited stimulus-torque responses charac-
teristic of plantarflexor muscles with slow contractile properties
(Hidler et al., 2002; Pelletier and Hicks, 2010). Additionally,
in participants with motor complete and incomplete SCI (AIS
B&C), muscle cross-sectional area was positively correlated to
modified Ashworth scores (Gorgey and Dudley, 2008). In con-
trast, muscles of individuals with low measures of spasticity
displayed faster contractile properties compared to control mus-
cles, in line with the human studies described earlier (reviewed in
Biering-Sorensen et al., 2009).
Collectively, these results indicate that similar to exercise (Roy
et al., 1999), the involuntary activity present in spastic muscles
allows some retention of normal muscle fiber type composition
and contractile properties; however, the muscles still remainmore
fatigable. Increased fatigability after SCI in humans appears to be
related to changes in the muscle (Klein et al., 2006). For exam-
ple, the metabolic capacity of muscle, as measured by oxidative
enzyme activity (Shields, 1995; Wang et al., 1999) and concen-
trations of Na+/K+-ATPase (Ditor et al., 2004), is correlated to
the amount of fatigue resistance in individuals with SCI (Shields,
1995). In summary, although spastic muscle activity promotes
slow contractile and fiber-type properties of muscle, it is not
enough to preserve fatigue resistance. Treatments such as inten-
sive exercise (Roy et al., 1999) or electrical stimulation (Rochester
et al., 1995; Gerrits et al., 2002, 2003) are likely also needed to
improve muscle endurance via increases in oxidative capacities of
the muscle (Gerrits et al., 2003).
MUSCLE CONNECTIVE TISSUE
Similar to muscle, remodeling of non-muscle tissue also occurs
after SCI. For example, after SCI in humans atrophic myofibers
become replaced by adipocytes, collagen, and other amorphous
substances (Scelsi et al., 1982; Olsson et al., 2006). It is thought
that these morphological changes increase the intrinsic stiffness
of the muscle (Mirbagheri et al., 2001; Schleip et al., 2006).
However, in individuals with increased passive tension in the
vastus lateralis at the whole muscle and muscle fiber level, specif-
ically in type IIb(x) fibers, there were no changes in passive
tension at the myofibril level (Olsson et al., 2006; Malisoux et al.,
2007). Likewise, the muscle protein titin, a main contributor
to passive tension (Horowits et al., 1986; Labeit and Kolmerer,
1995), remained unchanged in spastic muscles when compared
to control muscles, as did the properties of the intermediate fil-
aments (Olsson et al., 2006). Thus, as muscle atrophy occurs,
the increased passive tension evident at the whole muscle and
muscle fiber level is likely not due to structural changes of the
myofibril, but rather due, in part, to the replacement of myofibrils
by amorphous substances such as collagen and connective tissue
(Scelsi et al., 1982; Olsson et al., 2006). Moreover, adaptations to
extracellular and joint tissues may also contribute to joint stiff-
ness after SCI, but these changes have only been demonstrated in
immobilization models (Gracies, 2005).
In summary, changes in muscle and non-muscle tissue, com-
bined with adaptations to preserved spinal circuitry as described
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next, likely contributes to spastic motor behaviors after SCI.
For example, increases in muscle stiffness and changes in the
joint angles that produce optimal torque may contribute to the
decreased threshold and increased gain of the stretch reflex path-
way that mediate, in part, the oscillatory activation of muscles
during clonus (de Vlugt et al., 2012).
CHANGES IN MOTONEURON PROPERTIES AFTER SCI
SPINAL SHOCK
Immediately after injury, the spinal cord enters a state of “spinal
shock” (Ditunno et al., 2004; Dietz, 2010) that is characterized
by severe muscle paralysis, flaccid muscle tone (Bastian, 1890;
Sherrington, 1899, 1909) and an initial loss of reflexes and sen-
sation caudal to the lesion (Leis et al., 1996; Little et al., 1999;
Ditunno et al., 2004; Dietz, 2010). The duration and severity of
spinal shock differs between species, lasting only minutes to hours
in the frog (Hall, 1850), cat (Sherrington, 1899; Hunt et al., 1963;
Chambers et al., 1966) and dog (Sherrington, 1899; Fulton and
Sherrington, 1932) but up to 2 weeks in themonkey (Sherrington,
1899; Fulton and Sherrington, 1932; Hunt et al., 1963; McCouch
et al., 1966), rat (Bennett et al., 1999) and several weeks in
humans (Ko et al., 1999). In humans, all reflexes are absent only
for the first 24 h after SCI (Phase 1) (Ditunno et al., 2004), which
coincides with the first 2 weeks of areflexia in the rat tail model
of SCI (Bennett et al., 1999). By 1–3 days post-injury, human H-
reflexes and cutaneous reflexes begin to return (Diamantopoulos
and Olsen, 1967; Ashby et al., 1974; Ko et al., 1999; Hiersemenzel
et al., 2000) while a delayed plantar response also develops (Phase
2: Ko et al., 1999; Ditunno et al., 2004). Phase 3, lasting 4 days to
1 month, is characterized by a gradual increase in all reflexes with
the disappearance of the abnormal plantar response. Spinal shock
in humans is considered resolved by 1–6 months post-injury with
eventual development of hyperreflexia, clonus andmuscle spasms
(Ko et al., 1999; Ditunno et al., 2004). Similarly in the rat, hyper-
tonus in flexor and extensor muscles, clonus and hyperreflexia
(cutaneous tail flick) develops by 2 months post-injury (Bennett
et al., 1999).
Several factors contribute to the initial suppression of spinal
cord excitability after SCI. For example, there is a slight hyper-
polarization (2–6mV) of the resting membrane potential in cat
(Cope et al., 1980; Schadt and Barnes, 1980) and rat motoneurons
(Li et al., 2007), which may explain why antidromic activation
of human motoneurons, as measured by F-waves, is difficult
acutely after SCI (Ashby et al., 1974). In contrast, H-reflexes, but
not tendon tap reflexes, recover during spinal shock, as shown
in both the cat (Hunt et al., 1963; Zapata, 1966) and human
(Weaver et al., 1963; Hiersemenzel et al., 2000). This suggests that
fusimotor drive is also reduced acutely after SCI given that ten-
don taps rely on muscle spindle excitability whereas H-reflexes do
not. Pre-synaptic inhibition of primary afferents is also increased
in spinal shock, as measured by increases in primary afferent
depolarization in cats (Quevedo et al., 1993).
One of the more prominent contributors to spinal shock is
likely the disappearance of dendritic, voltage-activated sodium
and calcium persistent inward currents (PICs) in motoneurons
acutely after SCI. PICs contain a TTX-sensitive persistent Na cur-
rent and a low-voltage activated, slowly inactivating L-type Ca
current (CaV1.3) that is sensitive to nimodipine (Li and Bennett,
2003). PICs act to amplify synaptic inputs (Lee and Heckman,
2000) and because they are activated sub-threshold to cell firing
(Bennett et al., 1998), PICs aid in the secure and rapid recruit-
ment of motoneurons (Lee and Heckman, 2000). After recruit-
ment, PICs produce a sustained depolarization, or plateau poten-
tial, which can last for many seconds to produce self-sustained
firing of the motoneuron in the presence of reduced synap-
tic inputs (Hounsgaard et al., 1984, 1986; Crill and Schwindt,
1986; Carlin et al., 2000; Powers and Binder, 2003; reviewed in
Heckman et al., 2005). For example, a 1-s long, sub-threshold
depolarization of the motoneuron by a sensory-evoked, excita-
tory post-synaptic potential (EPSP) activates a plateau potential
(Figure 1A), which then keeps the motoneuron discharging for
many seconds even though the synaptic input (EPSP, see hyper-
polarized trace) has subsided. During spinal shock, PICs are no
longer activated in response to sensory stimulation. In motoneu-
rons of acutely injured rats (Figure 1B), the same 1-s long EPSP
does not activate a plateau potential and subsequently, self-
sustained firing does not occur. Thus, the acute disappearance
of PICs dramatically reduces the excitability of the motoneuron
as the amplification and prolongation of synaptic inputs does
not occur. This, coupled with motoneuron hyperpolarization,
increases in pre-synaptic inhibition and decreases in background
synaptic and gamma motoneuron drive, renders the motoneu-
ron and spinal circuits unexcitable in the first days and weeks
after SCI.
RECOVERY OF MOTONEURON PICs
In the weeks and months that follow a SCI, neurons and neuronal
circuits below the injury adapt to inactivity by increasing intrin-
sic excitability. This recovered excitability is marked in human
SCI by increases in residual muscle strength, H-reflexes, F-wave
persistence and the return of flexor reflex responses (Leis et al.,
1996; Little et al., 1999; Hiersemenzel et al., 2000). In addition
to changes in the transmission of sensory inputs (as discussed
later on), motoneuron PICs also re-emerge in the weeks follow-
ing a SCI to contribute to both the recovery of motor function
and the development of spasticity. For example, the motoneu-
ron described previously in Figure 1A actually comes from a
rat whose sacral spinal cord was completely severed 2 months
previously and whose tail muscles developed prolonged mus-
cle spasms. Thus, the self-sustained activity in this motoneuron,
which is mediated by the PIC and subsequent plateau potential,
reflects the involuntary muscle spasms that develop in these ani-
mals. The long time course of the plateau potential, which can last
for several seconds, is mainly produced by the slowly inactivating
CaPIC given that the NaPIC inactivates over a few seconds (Lee
and Heckman, 2001; Miles et al., 2005; Harvey et al., 2006) and
blocking CaPICs greatly reduces long-lasting reflexes (LLR), i.e.,
spasms (Murray et al., 2011b).
Instead of producing prolonged plateau potentials, the per-
sistent NaPIC facilitates repetitive discharge of the motoneuron
and mediates the slow, but steady firing that is characteristic of
spontaneous motor unit discharge in individuals with chronic
SCI (e.g., 5Hz discharge in Figure 2C; Gorassini et al., 2004; see
also Zijdewind and Thomas, 2012). For example, in motoneurons
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FIGURE 1 | Re-emergence of PICs after chronic SCI. (A) Re-emergence of
PICs in a completely transected (S2) rat after chronic (>50 days post-injury)
SCI. Motoneuron recording in response to single pulse (3×’s sensory
threshold) dorsal root stimulation. At resting membrane potential
(−65mV, top trace), PIC activation produces a plateau potential and
self-sustained firing. Hyperpolarization of the motoneuron (−75mV, bottom
trace) deactivates the PIC, eliminating the long-lasting reflex (LLR or spasm)
and reveals the long (1 s) EPSP. (B) Spinal shock in acutely-spinalized rat
(hours after injury), same preparation and experimental set-up as in (A).
Note absence of long-lasting reflex response at resting membrane potential
(−65mV, top trace) due to elimination of PICs acutely after injury. The
long-duration motoneuron EPSP (∼1 s) appears acutely after injury as
revealed in hyperpolarized motoneuron (−78mV, bottom trace). Taken from Li
et al. (2004a).
from chronically spinalized rats, the NaPIC is activated shortly
after the upswing on the afterhyperpolarization (AHP) to pro-
duce a slow ramp and then acceleration in membrane potential
(Vm) which then triggers an action potential (see bottom trace
in Figure 2A). Following this, during the fast depolarizing phase
of the action potential (spike), the NaPIC deactivates but then
re-activates on the upsweep of the next AHP to slowly ramp up
the Vm and trigger another spike. In this way, the NaPIC helps
to regeneratively fire the motoneuron at interspike intervals that
are much longer than the duration of the AHP (marked by bar),
especially under conditions of weak or absent depolarizing synap-
tic drive (Li and Bennett, 2007). Thus, repetitive activation of
the NaPIC produces the slow but steady motoneuron firing often
observed after SCI (e.g., 1.8Hz firing in Figure 2A). In motoneu-
rons from acutely injured rats, there is little to no NaPIC as
demonstrated by the absence of a slow acceleration in Vm after
the AHP (first inset in Figure 2B, bottom trace). Because of this,
repetitive firing only occurs during a strong depolarizing drive, as
occurs during a large current injection (see third current pulse in
Figure 2B). The large current injection provides sufficient accel-
eration of the Vm after the AHP to bring the motoneuron to
threshold (second inset, bottom trace). Thus, without the con-
tribution of the NaPIC, the motoneuron can only fire under a
strong depolarizing drive, with interspike intervals that are close
to the duration of the AHP, resulting in faster firing rates (e.g.,
7.7Hz firing in Figure 2B).
Evidence for the activation of NaPICs in mediating the slow,
but steady firing in human motoneurons after SCI is demon-
strated by the increase in firing rate variability when volitional
drive is superimposed on a spontaneously active motor unit
(Figure 2C). Here, the steady but slow discharge of the motor
unit at 5Hz is thought to be mediated by the regenerative acti-
vation of a strong NaPIC under conditions of low, involuntary
depolarizing synaptic drive, similar to rat motoneurons. With the
introduction of volitional drive, synaptic noise to themotoneuron
increases and subsequently, both the firing rate of the motor
unit (e.g., 10Hz in Figure 2C), along with its spike-to-spike vari-
ability, increase (black symbols in Figure 2D). This suggests that
the faster, more variable firing is produced by the noisy depo-
larization from the voluntary synaptic drive that recruits the
motoneuron at random times during the slow, NaPIC-mediated
ramp in Vm. The relationship between firing rate and firing
variability is opposite in motor units from uninjured control
participants during increasing levels of voluntary drive (white
symbols in Figure 2D). Under low levels of voluntary drive, firing
rates are low (∼5Hz) but variable due to low levels of synap-
tic noise (EPSPs) that sporadically brings the Vm to threshold
after the AHP (Matthews, 1996). However, when voluntary drive
increases, so does the mean depolarizing drive to the motoneuron
and this helps to more consistently accelerate the Vm to threshold
after the AHP (as in Figure 2B). Thus, during strong voluntary
drive in uninjured individuals, firing rate variability at high rates
decreases because the interspike interval (ISI) is more dependent
upon the stable AHP rather than the synaptic noise (Miles et al.,
2005). For example, firing rate variability is low and plateaus
beyond 10Hz (ISI’s ≤ 100ms, Person and Kudina, 1971), likely
because the ∼100ms AHP occupies a larger proportion of the
ISI compared to at lower rates (ISI’s > 100ms) where random
synaptic noise has more opportunity to recruit the motoneu-
ron during the NaPIC-mediated, slow ramp in Vm. Interestingly,
when the firing rate in the SCI and uninjured motor units both
reach∼10Hz, the firing rate variability in the two groups become
similar, suggesting that at rates >10Hz, the AHP is the main
determinant of the ISI.
In summary, after SCI both CaPIC-mediated plateau poten-
tials and NaPIC-mediated regenerative firing allow motoneurons
to exhibit prolonged, involuntary firing in response to brief or
low-levels of depolarizing synaptic drive.
ESTIMATING PICs FROM HUMANMOTOR UNIT RECORDINGS
The use of paired motor unit recordings in humans has pro-
vided indirect evidence that PICs contribute to the involuntary
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FIGURE 2 | Slow, steady firing in rat and human motoneurons after
chronic SCI. (A) Top trace: Firing response of a motoneuron from a chronic
spinal rat in response to a brief depolarizing current pulse (∼2 nA). Note low
mean rate (1.75Hz) and small standard deviation (±0.27Hz) in firing. Bottom
trace: Magnification of top trace indicated by rectangle. Plateau activation
due to NaPIC is indicated by dotted line, and baseline membrane potential
(Vm) is represented by solid black line. Note the ramp and acceleration
(arrows) in Vm after each AHP due to NaPIC, producing interspike intervals
much longer than the duration of the AHP (gray bar). (B) Top trace: Firing
response of motoneuron from an acute spinal rat without plateau potentials
in response to large (∼4–5 nA) depolarizing current injections. Note increased
firing rate (7.68Hz) during large current pulse. Bottom trace: Magnification
of top trace as indicated by rectangle. Interspike intervals are now closer
to the duration of the AHP (gray bar) and lack NaPIC-mediated ramp
in Vm. (A,B) taken from Li et al. (2004a). (C) Slow, steady firing rate of
spontaneously-active soleus (SOL) and hamstrings (HAM) motor units from
two participants with incomplete SCI (5Hz firing). Note increase in firing rate
and variability during superimposed voluntary activation of the muscles (10Hz
firing). (D) Relationship between the firing rate variability [standard deviation
(SD)] and mean rate of motor units from SCI participants (black symbols) and
control, uninjured participants (white symbols). (C,D) taken from Gorassini
et al. (2004).
activation of motoneurons during muscle spasms in chronic
SCI. The basis of estimating PIC activation by using the fir-
ing profiles of two motor units (motoneurons) is demonstrated
from direct intracellular recordings in the rat (Figure 3A). For
example, the amplitude of the PIC can be estimated indirectly
during current clamp when the motoneuron is activated by a
triangular-shaped current injection (Bennett et al., 2001). Once
the PICs are activated, the added depolarization provided by the
PIC allows the motoneuron to fire at levels of injected current
(input) below that needed to recruit the motoneuron (below
top horizontal line: Figure 3Ai), with cell firing stopping only
when the injected current is substantially reduced (at second
horizontal line). The difference in injected current between dere-
cruitment and recruitment of the motoneuron (I) is then used
as a measure of the PIC amplitude because it is the amount of
current that needs to be removed to counteract the added depo-
larization provided by the PIC and stop the motoneuron from
firing.
Using the firing rate profiles of two motoneurons to estimate
the amplitude of the PIC requires that both cells receive a com-
mon input and that the firing rate of one of the motoneurons
(e.g., control motoneuron in Figure 3Aii) serves as an estimate
of the input to the second motoneuron (e.g., test motoneu-
ron). This is possible because the firing rate of a motoneu-
ron is linearly related to the amount of current injection (or
synaptic input) it receives once the PIC is fully activated, as
shown in Figure 3Aiii. Thus, when using the firing rate (F)
of the control motoneuron as a measure of input to the test
motoneuron (Figure 3Aiv), rather than the injected current, the
difference in firing rate of the control motoneuron at derecruit-
ment and recruitment of the test motoneuron (dashed lines)
corresponds to the reduction in input that is required to coun-
teract the added depolarization from the PIC (Fderecruitment-
Frecruitment = F). Dividing the F value (5.7Hz) by the
slope of the F-I relationshipmeasured in Figure 3Aiii (4.2Hz/nA)
results in an estimation of current (1.4 nA) that is close to the
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FIGURE 3 | Estimating PICs in rat and human motoneurons. (A) Rat
motoneurons: Paired motor unit analysis (F) technique in rat motoneurons.
(i,ii) Firing rate profiles of a control and test motoneuron in response to the
same triangular current injection. Measurement of PIC as the difference in
current input at recruitment and derecruitment of the test motoneuron
(dashed lines): I value. (iii) Linear relationship between the firing rate and
injected current in the control motoneuron. (iv) The control motoneuron is
serving as a measure of input to the test motoneuron. Measurement of the
PIC as the difference in firing rate of the control motoneuron at recruitment
and derecruitment (dashed lines) of the test motoneuron: F value. (B)
Human motoneurons: F during muscle spasm in human SCI. Top trace:
Tibialis anterior (TA) surface EMG during sustained dorsiflexion and
application of transient vibration to TA tendon (gray squares) and medial arch
of the foot (black square). Middle trace: Firing rate of a higher-threshold TA
test unit in response to the vibrations. Bottom trace: Firing rate profile of
tonically active lower-threshold control motor unit. F is measured as the
difference in control unit rate at derecruitment and recruitment of test motor
unit (vertical lines and arrow). (A,B) taken from Gorassini et al. (2004).
amplitude of the PIC measured from the injected current profile
(1.3 nA in Figure 3Ai).
By using the firing rate profiles of two motoneurons (motor
units) as described above, the contribution of PICs to the acti-
vation of motoneurons during involuntary muscles spasms has
been estimated in participants with SCI (Figure 3B). Here the fir-
ing rate of a lower-threshold control motor unit from the tibialis
anterior (TA) muscle that is activated by vibration to the TA ten-
don (Figure 3B, bottom trace) is used as a measure of input to
the TA motoneuron pool and to a higher threshold test motor
unit. As evidence of this, vibration of the TA tendon (hatched
squares) produced a transient increase in the firing rate of the
control unit and a transient recruitment of a higher-threshold test
unit (Figure 3B: middle trace). Vibration of the tendon did not
produce a strong enough afferent input to evoke a muscle spasm.
However, vibration of the medial arch of the foot (Figure 3B:
black square) produced a greater increase in the firing rate of the
tonically-active control unit, signifying greater synaptic input to
the motor units, and consequently resulted in stable recruitment
of the higher-threshold test unit. In fact, the newly recruited test
unit continued to fire well after the removal of the vibratory input,
and exhibited sustained firing even at levels of synaptic input (as
measured by the firing rate of the control unit) well below the
level needed to recruit the test unit (difference between horizontal
lines, arrow indicates F). This difference indicates the activa-
tion of a PIC. By comparing the estimated PIC amplitude (F =
5Hz) to the total amount of rate modulation in the test unit
during a moderate contraction or involuntary spasm (∼12Hz),
it is estimated that the PIC provides ∼40% of the depolarizing
drive to the motoneuron during self-sustained firing (Gorassini
et al., 2004) and therefore, plays a major role in driving involun-
tary muscle spasms after SCI in humans. During stronger muscle
spasms, peak firing rates of motor units can reach as high as 35Hz
(Thomas and Ross, 1997) where the relative contribution of PIC
and synaptic activation of the motoneuron is unknown.
Using the paired motor unit technique to estimate PIC ampli-
tude (F) in human participants relies on the important assump-
tions that: (1) the firing rate of the control unit is an accurate
representation of its synaptic input and (2) the control unit
receives the same synaptic drive as the test unit (Gorassini et al.,
2004). Thus, it is important to measure the firing rate of the
control unit during periods of linear input-output which likely
occurs during moderate rates of discharge (5–20Hz) and dura-
tions of spike trains (10–20 s), to avoid firing rate saturation
and adaptation, respectively (Sawczuk et al., 1997; Brownstone,
2006). These values are based on firing rate properties of sacral
rat motoneurons that are similar to firing properties of human
motor units in the lower limb (Li et al., 2004a). Likewise, firing
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rates of the control unit during the first and last 1–2 s of activity
should be avoided as initial activation of PICs and AHP conduc-
tances, respectively, could affect the firing rate of the motoneuron
(Bennett et al., 1998; Wienecke et al., 2009). Finally, the correla-
tion between the smoothed firing rate of a control and test motor
unit should be high (correlation coefficient > 0.8) to ensure
that both units are receiving a common synaptic drive (De Luca
and Erim, 2002). Thus, F measures can provide a reasonable
estimate of PIC amplitude when the above conditions are fol-
lowed. However, one must keep in mind that it is not possible
to directly measure the linearity of the input-output relation of
human motoneurons.
MODULATION OF MOTONEURON PICs BY MONOAMINE RECEPTORS
In addition to being voltage-sensitive, PICs require the con-
comitant activation of serotonergic (5-HT) or noradrenergic
(NA) receptors located on the motoneurons. Serotonin is syn-
thesized from the amino acid, L-tryptophan, via the enzymes
L-tryptophan hydroxylase and amino acid decarboxylase (AADC)
(Feldman et al., 1997). Neuronal excitability is modified by 5-
HT via seven main types of receptors, 5-HT1−7, which are all
G-protein coupled receptors (GPCRs) except for the ligand-
activated 5-HT3 receptor (Boess and Martin, 1994; Hoyer et al.,
2002; Nichols and Nichols, 2008). PICs on motoneurons are
modulated by 5-HT2B/C receptors specifically (Miller et al.,
1996; Murray et al., 2011a). Noradrenaline, like dopamine and
adrenaline, is a catecholamine synthesized by adrenal chromaf-
fin cells and sympathetic nerves and is converted from the amino
acid L-tyrosine into L-Dopa via tyrosine hydroxylase (Kopin,
1968). L-Dopa is then converted into dopamine via AADC
and subsequently into noradrenaline via the enzyme dopamine
beta hydroxylase (DβH). Noradrenaline exerts its actions via
three main different types of GPCRs: α1, α2, and β subtypes
(Ahlquist, 1980; Bylund, 1992), where α1 receptors are cou-
pled to downstream Gq pathways and affect motoneuron PICs,
similar to 5-HT2 receptors (Gershengorn, 1989; Minneman and
Esbenshade, 1994; Lee and Heckman, 1996) and α2 receptors are
coupled to downstream Gi pathways to affect sensory transmis-
sion, similar to 5-HT1 receptors (Ruffolo et al., 1991; Murray
et al., 2011b). The major source of serotonin to the spinal
cord, as identified in rodents, comes from 5-HT containing neu-
rons in the medullary raphe pallidus (B1), raphe obscuris (B2),
raphe magnus (B3) and from adjacent parts of the reticular
formation (reviewed in Schmidt and Jordan, 2000). The dorsal
horn is mainly innervated by neurons from the raphe magnus,
whereas motoneurons in the ventral horn receive 5-HT inputs
mainly from the raphe pallidus and obscuris. The A5, A6 (locus
coeruleus) and A7 NA cell groups in the pontine region provide
the major source of NA fibers to the spinal cord, with a predomi-
nant innervation of the dorsal horn by A6 axons and of the ventral
horn by A7 axons (Bruinstroop et al., 2012).
The role of 5-HT and NA receptors in facilitating motoneu-
ron PICs was first demonstrated in the decerebrate cat where
PICs and sustained reflex responses were blocked by methy-
sergide; a 5-HT andNA receptor blocker (Hounsgaard et al., 1986,
1988). Likewise, immediately following a complete spinal transec-
tion where descending sources of 5-HT and NA were abolished
(i.e., acute injury), PICs were reduced or eliminated but could
be subsequently restored with an intravenous application of 5-
HTP, a 5-HT precursor (Hounsgaard et al., 1988) or by L-DOPA
(Conway et al., 1988), indicating loss of 5-HT2 andNAα1 receptor
activity. In contrast to acute SCI, serotonergic and NA receptors
are tonically activated onmotoneurons below a complete, chronic
transection, as evidenced by the reduction of PIC activation and
spasms by cyproheptadine, a 5-HT2 and NAα1 receptor blocker
(Figure 4A). Interestingly, the activation of these monoaminergic
receptors occurs even though there is a marked disappearance of
both 5-HT and NA fibers and their monoamines below the lesion
within 7 and 9 days after injury (Carlsson et al., 1963; Anden
et al., 1964). For example, in rat spinal cords there is a reduc-
tion in immunolabeling for 5-HT below the lesion 2 months after
a complete transection (Figure 4B). As will be described below,
the reactivation of 5-HT2 and NAα1 receptors on the motoneu-
ron, and the recovery of PICs in chronic SCI, results from an
FIGURE 4 | Endogenous activation of 5HT2/NAα1 receptors with little
monoamines below injury. (A) Top trace: Intracellular recording from
motoneuron of chronic spinal rat. Single-pulse, dorsal root stimulation evokes
long-lasting plateau potential and self-sustained firing. Bottom trace: Blocking
of 5-HT2 and NAα1 receptors with cyproheptadine eliminates PIC-mediated
plateau potential and self-sustained firing, leaving only sensory-mediated
activation of motoneuron. (B) Immunofluorescence imaging of residual
serotonergic fibers (beaded red) labeled with Texas-Red in spinal cords above
(left) and below (right) a complete spinal transection from a rat spinalized 2
months previously. (B) was taken from Murray et al. (2010).
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increase in monoamine receptors that can be activated without
the binding of 5-HT and NA. This “self-activation” of 5-HT2 and
NAα1 receptors is one strategy the spinal cord uses to regain its
lost excitability.
CONSTITUTIVELY-ACTIVE 5-HT2 AND NAα1 RECEPTORS
5-HT2 and NAα1 receptors are coupled to a hetero-trimeric G
protein which consists of an α, β, and γ subunit (Raymond
et al., 2001; Heckman et al., 2003). Activation of GPCRs induces
a conformational change in the receptor complex which results
in the release of the α-subunit by facilitating the exchange of
GDP for GTP. The dissociated α-subunit then acts to stimulate
the β isoform of the enzyme phospholipase C (PLC), resulting
in the hydrolysis of phosphatidylinositol bisphosphate into the
secondary messengers inositol trisphosphate (IP3) and diacyl-
glycerol (DAG). IP3 increases calcium mobilization via release of
intracellular, IP3-regulated calcium stores and DAG activates the
downstream protein kinase C (PKC) (Mizuno and Itoh, 2009)
which subsequently phosphorylates and activates voltage-gated
channels such as the Na and Ca channels mediating the PICs.
An interesting characteristic of GPCRs, like the 5-HT2 and NAα1
receptors, is their ability to display constitutive receptor activ-
ity (Gether et al., 1997; Seifert and Wenzel-Seifert, 2002; Berg
et al., 2005; Navailles et al., 2006). GPCRs exist in equilibrium
between inactive (R) and active (R∗) receptor states (Figure 5).
In the active state, the receptor is coupled to its G-protein and
can activate downstream signaling pathways, such as those which
facilitate the motoneuron PIC. Typically receptors enter their
active state only when the appropriate ligand binds to the recep-
tor complex (ligand-activation). However, different isoforms of
a receptor can also spontaneously enter their active state with-
out activation by a ligand and this is termed constitutive receptor
activity.
5-HT2C and NAα1 receptors demonstrate constitutive recep-
tor activity, as measured by basal IP3 levels and through
pharmacological methods in human (HEK -293) and monkey
(COS-7) kidney cells and in cultured mouse cortical neurons
(Herrick-Davis et al., 2000; Rauser et al., 2001; Berg et al., 2005;
Navailles et al., 2006; Chanrion et al., 2008). To examine if consti-
tutive activity in 5-HT2 andNAα1 receptors mediates the recovery
of motoneuron PICs in chronic injury, the effects of two types
of antagonists, an inverse agonist and a neutral antagonist, on
PIC-mediated LLR (spasms) has been examined, first in com-
pletely transected rats (Murray et al., 2010) and then in humans
with SCI (D’Amico et al., 2013b). An inverse agonist stabilizes
the receptor in its inactive resting state (R), preventing it from
entering into its active state (R∗). It also blocks other agonists
from binding to the receptor and thus, inverse agonists block both
constitutive receptor activity and conventional ligand-activation
of the receptor (Figure 5; Westphal and Sanders-Bush, 1994;
Herrick-Davis et al., 2000; Chanrion et al., 2008). In contrast, a
neutral antagonist works by only blocking the ligand activation
of the receptor. The 5-HT2 and NAα1 receptor inverse agonist,
cyproheptadine, and the selective 5-HT2 receptor inverse ago-
nist SB206553, both reduced PIC-mediated, LLR in chronically-
spinalized rats (Figures 6C,D: red traces/bars) and had no effect
on sensory-mediated, short-lasting reflexes (SLR). In contrast,
the neutral antagonists methysergide and SB242084, which only
block the ligand from activating the 5-HT2 and NAα1 recep-
tors, had no effect on PIC-mediated responses (Figures 6B,D:
blue traces/bars). Because the inverse agonist reduced 5-HT2 and
NAα1 receptor activity and its downstream effects (e.g., reduction
of PIC-mediated LLR) and the neutral antagonist had no effect,
then the effects of the inverse agonists can be attributed solely to
blocking receptors that were constitutively active. Furthermore,
mRNA analysis revealed an upregulation in the INI isoform of
the 5-HT2C receptor which displays the highest degree of consti-
tutive receptor activity (Murray et al., 2010). Consistent with the
mRNA findings, 5HT2C immunoreactivity is increased by 60%
in motoneurons below a complete transection (Ren et al., 2013).
FIGURE 5 | Mechanism of inverse agonists and neutral antagonists.
Receptor state equilibrium: Inactive state (R, left panel) of G-protein coupled
receptor (GPCR) where α, β, and γ subunits of the G-protein and downstream
pathways are not activated. Active receptor state (R∗, right panel) where the
α-subunit is released by facilitating exchange of GDP for GTP. Dissociated
α-subunit activates phospholipase C (PLC, not shown) resulting in the
hydrolysis of phosphatidylinositol bisphosphate into the secondary
messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3
increases calcium mobilization via release of intracellular, IP3-regulated
calcium stores and DAG activates the downstream protein kinase C (PKC)
which subsequently phosphorylates and activates voltage-gated channels
such as the Na and Ca channels mediating the PICs.
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FIGURE 6 | Constitutive receptor activity in chronic SCI rat. (A) In
vitro ventral root recordings in response to single-pulse (3 × T) dorsal
root stimulation in chronically spinalized (S2) rats. (B) PIC-mediated
long-lasting reflex (LLR: 500–4000ms after stimulation) before (black
trace) and after (blue trace) application of the neutral antagonist
SB242084. (C) Evoked LLR before (black trace) and after (red trace)
application of the inverse agonist SB206553. Inset shows the sensory
evoked, short-latency reflex (SLR: 10–40ms) that is not mediated by the
slow activating PICs or affected by the inverse agonist. (D) Group
means of the LLR (expressed as a % of pre-drug values) after
application of the neutral antagonists (blue), inverse agonists (red), and
application of inverse agonist after the receptor is first blocked with the
neutral antagonist (white) to render the inverse agonist ineffective. Taken
from Murray et al. (2010). ∗∗p < 0.01.
Evidence for constitutively active NAα1 receptors was also found
whereby the inverse agonists prazosin and WB4101 significantly
reduced PIC-mediated responses in chronic spinal rats whereas
the neutral antagonists methysergide (5-HT2/NAα1) and REC
(NAα1) had no effect (Rank et al., 2011). Thus, following com-
plete SCI in the chronic animal, the recovery of PIC activation in
themotoneuron occurs as a result of the emergence of constitutive
5-HT2 and NAα1 receptor activity.
To examine the emergence of constitutively-active monoamin-
ergic receptors after SCI in humans, similar pharmacological
methods have been employed in individuals with both motor
incomplete (iSCI: AIS C&D) and motor complete (cSCI: AIS
A&B) injury (D’Amico et al., 2013b). Oral administration of
cyproheptadine, the inverse agonist to 5-HT2 and NAα1 recep-
tors, also reduced PIC-mediated LLR in participants with incom-
plete SCI (Figure 7A) and had no effect on the sensory-mediated
SLRs similar to the rat (D’Amico et al., 2013b). In these same par-
ticipants oral intake of citalopram, a selective serotonin reuptake
inhibitor, increased the LLR (Figure 7B), indicating that resid-
ual levels of serotonin were present below the injury and likely
facilitated motoneuron PICs via ligand activation of the 5-HT2
receptors (see also Thompson and Hornby, 2013). Similar to
participants with incomplete SCI, participants with motor com-
plete injuries also displayed tonic activation of 5-HT2 and NAα1
receptors given that cyproheptadine also reduced PIC-mediated
LLR (Figure 7C). However, oral intake of the neutral antagonist,
chlorpromazine, had no effect on LLR (Figure 7D), even though
it was effective in reducing PIC-mediated F measures in unin-
jured controls having intact 5-HT and NA fibers (D’Amico et al.,
2013b). Based on these two findings, participants withmotor com-
plete SCI appeared not to have residual levels of 5-HT and NA
below the lesion so that PICs were solely facilitated by constitutive
activity in 5-HT2 andNAα1 receptors, similar to the complete SCI
model in rats. How the facilitation or control of these monoamine
receptors may be used to promote motor recovery or control
spasticity, respectively, will be discussed at the end of this review.
CHANGES IN SENSORY TRANSMISSION TO
MOTONEURONS AFTER SCI
EMERGENCE OF LONG-DURATION EPSPs
In addition to adaptive changes in the motoneuron, the transmis-
sion of sensory inputs to the motoneuron is also affected follow-
ing SCI. One of the main changes is the loss or reduction of early,
inhibitory post-synaptic potentials (IPSPs) and the conversion to
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FIGURE 7 | Constitutive receptor activity in chronic human SCI. (A)
Inverse agonist cyproheptadine in a motor incomplete SCI participant (iSCI,
AIS C). Unrectified surface EMG during long-lasting reflex (LLR) evoked in
the TA muscle from medial arch stimulation before (top trace) and after
(bottom trace) 8mg of oral cyproheptadine. Note reduction in the
presumably PIC-mediated long-lasting reflex (LLR: 500ms after stimulation
onwards). (B) Serotonin re-uptake inhibitor citalopram in iSCI (AIS C)
participant. Long-lasting reflex (LLR) recorded in TA muscle before (top
trace) and after (bottom trace) 20mg of oral citalopram. (C) Same as in (A)
but for 12mg oral dose of cyproheptadine in motor and sensory complete
SCI participant (cSCI, AIS A). (D) Effect of neutral antagonist
chlorpromazine (12.5mg) on PIC-mediated LLR in same cSCI participant.
(A–C) taken from D’Amico et al. (2013b).
pure, prolonged EPSPs in response to brief, sensory stimulation
(Baker and Chandler, 1987). As demonstrated in Figure 1, follow-
ing acute or chronic SCI, a single pulse of electrical stimulation
to a sacral dorsal root, which contains predominantly cutaneous
afferents, produced a very long (∼1 s) EPSP that was depen-
dent upon the activation of NMDA channels (Bennett et al.,
2001). The profile of this EPSP was revealed by blocking voltage-
dependent conductances with cell hyperpolarization so that the
synaptic activation profile of the motoneuron predominated (Li
et al., 2004a). This 1-s EPSP provided a long enough depolariza-
tion of the motoneuron to activate the CaPIC, the latter requiring
at least 500ms of synaptic depolarization to activate (Moritz
et al., 2007; Murray et al., 2011b). Thus, when the motoneu-
ron PIC recovers after chronic SCI, the long EPSP can trigger
plateau potentials and self-sustained firing that is unchecked
due to the loss of descending and intrinsic inhibition of the
motoneuron, resulting in the activation of involuntary muscle
spasms.
The loss of IPSPs and conversion to pure EPSPs in response
to cutaneomuscular stimulation is also evident in the activation
profile of motoneurons (motor units) recorded in participants
with chronic, incomplete SCI (Norton et al., 2008) using the
peristimulus frequencygram (PSF) technique (Awiszus et al.,
1991; Turker and Powers, 1999, 2003). To construct a PSF, the
instantaneous firing rate of a tonically activated motor unit is
plotted time-locked to a sensory stimulus (Figure 8). Because
the firing rate of a motoneuron mainly reflects the net current
reaching the soma (Baldissera et al., 1982; Powers et al., 1992),
any modulation in firing rate from a sensory stimulus should
reflect the underlying shape of the EPSP or IPSP (Turker and
Powers, 1999, 2003). For example, the firing rate of a tonically
active motor unit recorded from the TA muscle of an incom-
plete SCI participant increased above baseline for a duration
of ∼1 s in response to stimulating cutaneomuscular afferents
from the medial arch of the foot. This was most likely due to
an EPSP lasting for ∼1 s, similar to that measured in motoneu-
rons from chronically spinalized rats (Figure 1A). In a control
participant (Figure 8B), the PSF only lasted for ∼300ms, with a
pause in firing after the initial acceleration in rate and an inter-
posed cluster of action potentials at firing rates near or below
the mean background rate (gray circle: Figure 8B). The shape of
this PSF was likely mediated by a 300ms long EPSP that con-
tained a brief, interposed IPSP. To demonstrate this, a current
profile was injected into a hyperpolarized motoneuron from a
chronic spinal rat (inset in Figure 8C) to produce the hypothe-
sized PSP (gray trace in Figure 8C). When a steady current was
injected into the motoneuron to produce tonic firing and the sim-
ulated current profile was then added, the resulting PSF (black
dots in Figure 8C) was similar to the PSF recorded in the control
participant (Figure 8B). Thus, it has been proposed that, unlike
uninjured control participants, robust IPSPs from cutaneomus-
cular afferent stimulation are not activated in motoneurons of
SCI participants and are replaced by prolonged EPSPs. These
1 s-long EPSPs produce a long enough depolarization of the
motoneuron to activate CaPICs and trigger self-sustained fir-
ing, resulting in the activation of unchecked, involuntary muscle
spasms.
The animal and human studies described above mainly exam-
ined changes in the transmission of cutaneous reflex pathways.
As described next, transmission in other sensory pathways is also
altered after SCI. Generally, transmission is increased in excitatory
reflex pathways and reduced in inhibitory reflex pathways.
PRE-SYNAPTIC INHIBITION
Pre-synaptic inhibition effectively modulates the efficacy of affer-
ent transmission to the motoneuron via primary afferent depo-
larizing interneurons (PAD INs, gray neurons in Figure 9A).
Although pre-synaptic inhibition can occur at all afferent termi-
nals, studies in humans havemainly focused on pre-synaptic inhi-
bition of Ia afferents. The mechanisms of pre-synaptic inhibition
involve the activation of fast, ionotropic γ-aminobutyric acidA
(GABAA) receptors and slow, metabotropic GABAB receptors.
Activation of GABAA receptors on primary afferent terminals
produces an efflux of Cl− resulting in primary afferent depolar-
ization and subsequently, reducing the size of the propagating
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FIGURE 8 | Peristimulus frequencygrams (PSF) in SCI and uninjured
participants and in rat. (A) PSF of TA motor units recorded in
incomplete SCI participant (AIS C) in response to stimulation of the
medial arch of the foot (time marked by arrow, 0.2ms pulse width, 3
pulses, 300Hz, ∼50mA) while participant maintained tonic dorsiflexion.
Mean rate indicated by solid gray line. (B) PSF recorded from uninjured
control participant in response to same medial arch stimulation. Note
shorter duration of response, pause and cluster of motor unit action
potentials as marked by the dashed gray circle. (C) PSF (black dots)
recorded in rat motoneuron that mimics the PSF obtained in the
uninjured control participant from (B). The intracellular current injection
profile required to obtain this PSF is shown in inset and the resulting
Vm response (gray trace) to this injected profile in a hyperpolarized
motoneuron. Taken from Norton et al. (2008).
action potential. This ultimately results in less calcium influx
and less neurotransmitter release (Rudomin and Schmidt, 1999;
Seki et al., 2003; Rudomin, 2009). In contrast, G-protein cou-
pled GABAB receptors directly modulate the calcium channels
in afferent terminals, resulting in less calcium influx and sub-
sequently, less neurotransmitter release (Rudomin and Schmidt,
1999; Castro et al., 2006; Soto et al., 2006).
Mailis and Ashby (1990) examined transmission from Ia
afferents to motoneurons after SCI by recording motor unit
action potentials in the soleus muscle in response to low-
intensity (∼0.8 xMT) posterior tibial nerve stimulation (lower
red path in Figure 9). In only the most spastic SCI partici-
pants, the peak amplitude of the post-stimulus time histogram
(PSTH) at the Ia monosynaptic latency was augmented (first
peak in Figure 9B). In addition, there was the emergence of
a second peak 11–15ms later (at arrow in Figure 9B), sug-
gesting the emergence of an oligosynaptic, group I excitatory
pathway. To examine if this enhanced response was due to a
reduction in pre-synaptic inhibition on the Ia afferent termi-
nals, paired electrical stimulation of homonymous afferents from
the soleus muscle was used (Birnbaum and Ashby, 1982; Lev-
Tov et al., 1983). A prior conditioning stimulus (0.8 xMT) was
applied to the posterior tibial nerve to activate PAD INs (upper
red pathway in Figure 9), which in turn pre-synaptically inhib-
ited Ia afferents with monosynaptic connections onto soleus
motoneurons (lower red pathway). Here, the first peak of the
PSTH was produced by the arrival of Ia inputs from the first
conditioning volley and the second peak from the test volley
(Figure 9C). In controls, the second peak in the PSTH was
reduced in comparison to the first peak at interstimulus inter-
vals (ISIs) of 20 and 50ms, likely due to pre-synaptic inhibi-
tion of Ia afferents from the first conditioning volley (upper
red pathway). Reduction of the second peak was smaller or
absent in the SCI participants (Figure 9C), indicating a reduction
in homonymous, pre-synaptic inhibition (Mailis and Ashby,
1990).
Reduction of pre-synaptic inhibition from heteronymous
nerves, using the techniques of Hultborn et al. (1987) and
Meunier and Pierrot-Deseilligny (1989), was also examined
after SCI. Excitatory monosynaptic inputs from quadriceps Ia
afferents (blue pathway in Figure 9A) can facilitate the soleus
H-reflex (lower red pathway) but the amount of this facili-
tation is modulated by the amount of pre-synaptic inhibition
that is tonically present on the quadriceps Ia afferent termi-
nals, likely from descending pathways (marked as black dashed
line, Figure 9A). Heteronymous facilitation of the soleus H-
reflex by quadriceps Ia afferents (4–5 xMT, ∼80ms ISI) was
greater in SCI participants compared to uninjured controls,
indicating reduced levels of background pre-synaptic inhibition
after SCI (Faist et al., 1994). Pre-synaptic inhibition of soleus
Ia afferent terminals through PAD interneurons can also be
activated by afferents supplying the antagonist tibialis anterior
muscle (TA, Figure 9A, green pathway). In uninjured controls,
conditioning the TA afferents produces two phases of inhibi-
tion onto soleus motoneurons: an early D1 inhibition at ISIs
of 10–25ms and a late, longer-lasting D2 inhibition at ISIs
of 70–200ms (Mizuno et al., 1971). A pre-synaptic site for
the inhibition was proposed since the same conditioning vol-
leys did not suppress cortical motor evoked potentials (MEPs)
in the soleus, thereby excluding post-synaptic inhibitory mech-
anisms (Capaday et al., 1995; Faist et al., 1996). When an
H-reflex in the flexor carpi radialis (FCR) muscle was condi-
tioned by a prior stimulation to the antagonist radial nerve (0.95
xMT, 13ms ISI), there was no early D1 inhibition in the ago-
nist H-reflex in tetraplegic participants, indicating reduced pre-
synaptic inhibition of Ia afferents in the median nerve (Aymard
et al., 2000). In summary, pre-synaptic inhibition appears to
be significantly reduced after SCI, likely resulting, in part,
from decreased descending facilitation of PAD INs (Figure 9A).
However, there is no correlation between the reduction in pre-
synaptic inhibition and Ashworth scores of spasticity (Faist et al.,
1994).
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FIGURE 9 | Pre-synaptic and reciprocal inhibition in humans. (A)
Pre-synaptic and reciprocal inhibitory pathways. Red trace: Monosynaptic Ia
pathway to soleus (Sol, lower pathway) and homonymous activation of PAD
interneurons (upper pathway). PAD interneurons marked by gray circles. Blue
trace: Heteronymous, monosynaptic facilitation of soleus motoneurons by
quadriceps (Q) Ia afferents that are tonically inhibited by PAD Ins, the latter
activated by descending pathways (dashed line). Green trace: Reciprocal
inhibitory pathway from tibialis anterior (TA) afferents onto soleus Ia reciprocal
inhibitory interneuron (black circle) and onto soleus PAD interneuron via
second order interneuron (D1/D2 inhibition). (B) PSTH obtained from a SCI
participant in response to low-threshold electrical stimulation of the posterior
tibial nerve (bottom red pathway in A). Note second peak in PSTH (arrow). (C)
Decrease of second PSTH peak in response to paired activation (20ms ISI) of
posterior tibial nerve in uninjured control (top trace) but not SCI (bottom trace)
participant indicative of reduced pre-synaptic inhibition (top red pathway in A).
(B,C) were modified from Mailis and Ashby (1990).
RECIPROCAL INHIBITION
Reciprocal Ia inhibition is a disynaptic pathway through Ia
interneurons (black neuron, Figure 9A) that is activated by
Ia afferents from the agonist (e.g., TA) muscle and inhibits
motoneurons of the antagonist (e.g., soleus) muscle. Activation
of Ia inhibitory interneurons ensures that antagonist muscles
remain relaxed during contraction of the agonist muscle, pre-
venting undesired co-contractions. Reciprocal inhibition can be
measured by conditioning a test H-reflex evoked in the antago-
nist muscle with a low-threshold stimulation (0.8–1.0 xMT, ISIs
2–4ms) to the nerve supplying the agonist muscle (Kots and
Zhukov, 1971; Mizuno et al., 1971; Crone et al., 1987). In SCI
participants, suppression of the soleus H-reflex by a prior condi-
tioning stimulation of the common peroneal nerve supplying the
TA muscle was greatly reduced compared to control participants
and, in some cases, replaced by reciprocal facilitation (Crone
et al., 2003). Although it is apparent that reduced reciprocal
inhibition may contribute to increased motoneuron excitability
after SCI, there is no correlation between the strength of recip-
rocal inhibition and the degree of spasticity, as measured by the
Ashworth scale (Crone et al., 1994; Nielsen et al., 2007).
POST-ACTIVATION DEPRESSION
Post-activation (or rate-dependant) depression (PAD2) of H-
reflexes occurs when the same (homonymous) Ia afferent pathway
is repetitively activated (Crone and Nielsen, 1989). PAD2 pro-
duces a strong, long-lasting (∼10 s) inhibition of H-reflexes and
motoneuron activity (Magladery et al., 1952; Rothwell et al., 1986;
Crone and Nielsen, 1989; Hultborn et al., 1996). The mechanism
of PAD2 is unknown and may include decreases in neurotrans-
mitter release at the Ia-motoneuron synapse (Hultborn et al.,
1996; Kohn et al., 1997) or frequency-dependent facilitation of
inhibitory spinal interneurons (Boulenguez et al., 2010). The level
of PAD2 can be measured by examining the gradual decrease in
H-reflex size when trains of reflexes are elicited at incrementing
frequencies between 1 and 10Hz (Lloyd andWilson, 1957). PAD2
is reduced in individuals with SCI (Schindler-Ivens and Shields,
2000) and can be increased by a single bout of treadmill train-
ing (Trimble et al., 1998). Additionally, PAD2 can be measured by
examining the reduction of H-reflexes by homonymous tendon
vibration because the vibration repeatedly activates the same Ia
afferents recruited during the H-reflex. Tendon vibration failed to
attenuate H-reflexes in participants with chronic SCI compared to
uninjured controls, again indicating reduced PAD2 (and/or classi-
cal pre-synaptic inhibition) as a possible contributor to enhanced
sensory transmission and the triggering of muscle spasms after
SCI (Calancie et al., 1993).
FLEXOR WITHDRAWAL REFLEXES
Flexor reflex afferent (FRA) pathways include group II, joint
and cutaneous afferents that activate ipsilateral flexors and con-
tralateral extensors and inhibit ipsilateral extensors. In uninjured
participants, noxious cutaneous stimulation produces an exci-
tatory, short-latency (∼50–70ms) flexor withdrawal response
with a duration of ∼50ms (Pedersen, 1954; Shahani and Young,
1971). In participants with motor complete SCI, this short
latency response is not present and is replaced by a long-latency
(>100ms) excitation of flexors at both high and low intensities
of stimulation (Roby-Brami and Bussel, 1987). A long-latency
FRA response can also be obtained in uninjured participants
but only at high stimulation intensities (Shahani and Young,
1971). In spinalized cats the early and late FRA responses are
produced from distinct pathways whereby the early FRA path-
way tonically inhibits the late FRA pathway. This inhibition can
be released by the application of L-DOPA and NA, resulting
in the emergence of long FRA responses that are similar to
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those present in individuals with complete SCI (Anden et al.,
1964, 1966a,b; Jankowska et al., 1967; Lundberg, 1979). The
development of constitutive NAα1 receptor activity on interneu-
rons in the FRA pathway, which has been shown to occur
on motoneurons (Rank et al., 2011), may contribute to the
unmasking of long FRA reflexes after motor complete SCI in
humans.
MECHANISMS FOR REDUCED SPINAL INHIBITION AFTER
SCI
The excitability of several inhibitory spinal pathways is reduced
after SCI and likely contributes to the prolonged EPSPs that read-
ily trigger PICs and spasms. As discussed below, inhibition and
the regulation of excitatory sensory pathways is influenced by
several factors.
DEPOLARIZATION OF CHLORIDE REVERSAL POTENTIAL
The strength of IPSP activation in neurons is modulated
by the activity of a potassium-chloride cotransporter (KCC2,
Figure 10A) which removes chloride from the neuron in exchange
for potassium to maintain the chloride equilibrium potential
below rest at ∼75mV (Price et al., 2005). When GABAA and
glycine receptors are activated, Cl− flows into the neuron to pro-
duce IPSPs due to the low intracellular concentration of Cl−.
Following SCI, there is a downregulation and decreased mem-
brane insertion of KCC2 (Boulenguez et al., 2010), resulting in
an increase in intracellular Cl− concentration and an ∼10mV
depolarization of the Cl− reversal potential in 6–8 day old rats
(Figure 10B). In adult rats, the depolarization of the Cl− rever-
sal potential is less at ∼5mV (Murray et al., 2011b). The 10mV
depolarization of the Cl− reversal potential to above the rest-
ing membrane potential in neonates subsequently results in a
switch from GABAA and glycine-mediated inhibition to excita-
tion because chloride moves out of the cell rather than into the
cell during activation of the receptors (Boulenguez et al., 2010).
Such a reversal was not seen in adult rats but the 5mV depo-
larization of the Cl− reversal potential to near rest likely shifts
the balance of EPSP activation over IPSP activation after SCI, as
shown for the PSF profiles in the human (Figure 8; Norton et al.,
2008). Functionally, the reduction of KCC2 activity results in a
decrease of rate-dependent depression (or PAD2) of the H-reflex
in rats (Boulenguez et al., 2010) and may mediate the reduction
of other spinal inhibitory networks such as those activated during
reciprocal inhibition and cutaneomuscular reflexes. Interestingly,
rate-dependent depression (or PAD2) of the H-reflex can be
restored via activation of TrkB receptors with BDNF after SCI (but
not in intact animals), which also produces an upregulation of the
KCC2 cotransporter (Boulenguez et al., 2010). Activation of 5-
HT2A receptors on the motoneuron, via a calcium-independent
PKC pathway, also restores KCC2 expression and rate-dependent
depression of the H-reflex after SCI in rodents (Bos et al., 2013).
Thus, strategies which enhance KCC2 activity may restore intrin-
sic inhibition to the spinal cord to reduce spasticity after SCI. The
specific 5-HT2A receptor agonist used in this study (TCB-2) is
not yet available for human use and it is likely that other 5-HT2A
receptor agonists (e.g., DOI) would have hallucinogenic effects
(Sadzot et al., 1989).
FIGURE 10 | KCC2 cotransporter and chloride equilibrium before and
after SCI. (A) A potassium chloride cotransporter (KCC2) removes chloride
(Cl−) from the motoneuron (MN) in exchange for potassium (K+) to
maintain Cl− equilibrium potential below resting membrane potential,
allowing Cl− influx and MN hyperpolarization during activation of GABA and
Glycine receptors (R). (B) Downregulation of KCC2 expression in
motoneurons after SCI increases intracellular Cl− concentration,
depolarizing Cl− equilibrium potential to above rest. This produces efflux of
Cl− and depolarization of MN during activation of GABA and Glycine
receptors. Activation of 5-HT2A receptors increases cell membrane
expression of KCC2 after SCI to restore endogenous inhibition.
DISINHIBITION FROM DECREASED MONOAMINE RECEPTOR
ACTIVATION
In addition to facilitating motoneuron PICs, serotonin and
noradrenaline also regulate sensory transmission pre- and post-
synaptically via the activation of Gq and Gi-coupled receptors.
For example, activation of Gq-coupled 5-HT2 and NAα1 recep-
tors on Ia and Ib inhibitory interneurons facilitates Ia recipro-
cal and Ia/Ib non-reciprocal inhibition (Jankowska et al., 2000;
Hammar and Jankowska, 2003). Activation of Gi-coupled 5-HT1
and NAα2 receptors on the terminals of group I/II muscle, skin
and high threshold pain afferents and on excitatory interneurons,
such as propriospinal and group II interneurons, reduces trans-
mission in these pathways (Jankowska et al., 1993, 1994; Rekling
et al., 2000; Millan, 2002; Yoshimura and Furue, 2006; Jordan
et al., 2008). Because there is a dramatic loss of serotonin and
noradrenaline below a SCI, recent experiments have examined
the effects of administering specific 5-HT1 and NAα2 receptor
agonists to restore control over sensory afferent transmission to
the motoneuron. As mentioned previously, a single-shock stim-
ulation to a dorsal root produces a 1-s long EPSP as revealed
during cell hyperpolarization (bottom trace, Figure 11Ai). This
EPSP contains both a short-latency, short-duration component
(short EPSP) and a longer-latency, longer-lasting component
(long EPSP). At rest (−72mV), the long EPSP produced by the
dorsal root stimulation activates a CaPIC to produce a plateau
potential and self-sustained firing or long-lasting reflex response
(LLR, top trace Figure 11Ai). When the specific agonist to the
5-HT1B/D receptor, zolmitriptan, was applied the long (but not
short) EPSP was eliminated (bottom trace, Figure 11Aii) so that
at rest, a plateau potential and LLR was not triggered (top
trace, Figure 11Aii). Testing with multiple 5-HT1 receptor ago-
nists/antagonists showed that sensory transmission is mainly
produced by the specific activation of 5-HT1B and 5-HT1F recep-
tors (Murray et al., 2011b). Application of an agonist to the NAα2
receptor, clonidine, also reduced the long sensory-evoked EPSP
to prevent triggering of plateaus/LLRs (Rank et al., 2011). Both
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FIGURE 11 | Effect of zolmitriptan on sensory transmission in SCI rat and
human. (A) Effects of zolmitriptan in chronically injured rat motoneurons.
(i)Top trace: Intracellular recording from chronic spinal rat motoneuron at rest
(−72mV) where single-pulse dorsal root stimulation produces PIC-mediated
long-lasting reflex (LLR). Bottom trace: same motoneuron hyperpolarized to
−80mV to reveal short and long EPSP in response to dorsal root stimulation.
(ii) Recording from same motoneuron in (i) at rest (top trace) and during
hyperpolarization (bottom trace) after application of the 5HT1B/D receptor
agonist zolmitriptan. Note elimination of the long-duration EPSP which
prevents the triggering of the PIC-mediated long-lasting reflex. Taken from
Murray et al. (2011b). (B) Unrectified EMG showing short- lasting reflex (SLR:
first 50ms of reflex response) recorded from the TA muscle in a single SCI
participantbefore (top trace) and after (bottom trace) 10mg oral zolmitriptan in
response to medial arch stimulation. ∗Marks time of stimulation. (C)
Unrectified TA EMG before (top trace) and after (bottom trace) 10mg
zolmitriptan in a single SCI participant in response to medial arch stimulation.
Black bar denotes long-lasting reflex response (LLR: 500ms after stimulation
and beyond). (B,C) were taken from D’Amico et al. (2013a).
of these findings indicate that facilitation of Gi-coupled 5-HT1
andNAα2 receptors can reduce transmission of excitatory sensory
pathways after SCI in rats.
Similar findings have been obtained in humans with motor
complete SCI where oral intake of zolmitriptan (10mg dose) sup-
presses the activation of (SLR, Figure 11B). The reduction of
these SLRs resulted in reduced triggering of the LLR responses
or spasms (Figure 11C), similar to the findings in the rat. The
reduction in spasms was likely not mediated by a reduction in
plateau potentials given that zolmitriptan does not affect the Na
or CaPIC (Murray et al., 2011b). The mainly monosynaptic H-
reflex was also reduced by zolmitriptan (D’Amico et al., 2013a).
The same dose of zolmitriptan had similar effects on the H-
reflex in uninjured control participants indicating that despite the
decreased levels of serotonin below the motor-complete injury,
the 5-HT1 receptors were not supersensitive. A tonic elevation
in the transmission of sensory inputs after SCI suggests there is
a low or absent level of basal 5-HT1 and NAα2 receptor activ-
ity below an injury. As such, it is unlikely that Gi-coupled 5-HT1
andNAα2 receptors display functional levels of constitutive recep-
tor activity, unlike the Gq-coupled 5-HT2 and NAα1 receptors on
motoneurons. Understanding why 5-HT1 and NAα2 receptors do
not become constitutively active may help devise new strategies to
control sensory transmission and spasticity after SCI.
Additional mechanisms producing enhanced sensory trans-
mission to motoneurons after SCI are reviewed in Roy and
Edgerton (2012) and include the suggestion by Kitzman (2005)
that a decrease in dendritic number, without a subsequent
increase in voltage-gated channels, may also increase the excitabil-
ity of motoneurons after SCI. Moreover, elevations in motoneu-
ron vesicular glutamate transporter 2 (2-IR), but not the 1-IR
transporter onmyelinated primary afferents, suggests that polysy-
naptic glutamatergic inputs from interneurons (but not from
monosynaptic pathways) are elevated after SCI (Kitzman, 2006,
2007). In addition to neuronal changes, overexpression of gluta-
mate receptor 1 (GluR1) on astrocytes has also been implicated in
exacerbating sensory-evoked spasms in an ischemic model of rat
SCI (Hefferan et al., 2007).
TREATMENTS FOR SPASTICITY AND RECOVERY OF
MOTONEURON FUNCTION
When involuntary muscle activity leads to impairments in func-
tion, difficulties in hygiene, skin breakdown and/or pain, treat-
ment is warranted. As discussed above, spasticity is caused by
adaptations to the muscle and spinal circuits as a result of a
disruption in descending activation of the spinal cord. Most treat-
ment strategies for spasticity target these secondary adaptations
with limited success. Strategies that aim to fix the primary cause
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of spasticity by enhancing functional descending and/or periph-
eral activation of the spinal cord, in both motor complete and
incomplete SCI, may prove to be more efficacious.
CURRENT PHARMACOLOGICAL TREATMENTS
Current pharmacological treatments for spasticity aim to sup-
press spinal cord or muscle activity. Three main sites are tar-
geted to reduce: (1) sensory transmission to motoneurons, (2)
motoneuron excitability and (3) muscle contractions (Figure 12).
Unfortunately when taken orally, these medications are not spe-
cific to the spinal cord or muscle and the majority produce some
generalized depression of the CNS, resulting in altered men-
tal states such as drowsiness and dizziness and in generalized
weakness (Satkunam, 2003). For many of these agents long-
term, high-dose use can also result in physiologic dependence
(Simon and Yelnik, 2010) such that sudden withdrawal can result
in serious consequences such as seizures (Grosset and Grosset,
2004). The most commonly prescribed agent for spasticity is
baclofen, a GABAB agonist which acts pre-synaptically (site 1,
Figure 12) to reduce the amount of excitatory neurotransmit-
ter released into synapses (Curtis et al., 1997; Li et al., 2004b).
Although oral baclofen can reduce spasticity, it has detrimen-
tal effects on walking in patients with incomplete SCI, where
other antispastics such as clonidine and cyproheptadine do not
(Wainberg et al., 1986, 1990; Norman et al., 1998; Barbeau and
Norman, 2003). Long-term use of oral baclofen also exacerbates
the weakness and fatigability of motor units (Thomas et al., 2010).
In cases of severe spasticity where patients are refractory to other
treatments, baclofen is applied to the cerebrospinal fluid sur-
rounding the spinal cord via an intrathecal pump (Lazorthes
et al., 1990; Stempien and Tsai, 2000; Krach, 2001). Although
intrathecal delivery reduces systemic side effects, it has a high rate
(1%/month) of serious complications such as catheter obstruc-
tion which results in sudden withdrawal of baclofen and requires
surgical intervention to repair (Draulans et al., 2013). Similar to
baclofen, tizanidine (and clonidine) enhances pre-synaptic inhi-
bition but via activation of NAα2 receptors on primary afferents
and excitatory interneurons (site 1, Figure 12) (Davidoff, 1985;
Krach, 2001). In one of the largest studies to date (78 SCI individ-
uals), tizanidine reduced Ashworth scores by 37% in comparison
to placebo (4%), with 81% of individuals reporting side effects
(54% placebo) and no change in activities of daily living (Nance
et al., 1994). Zolmitriptan also reduces sensory transmission by
binding to 5-HT1B receptors (site 1, Figure 12) (Murray et al.,
2011b) but is not used as an oral anti-spastic given that reg-
ular use can induce headaches (Limmroth et al., 1999) and it
is contraindicated in people with cardio-, cerebro-, or periph-
eral vascular disease (Peterlin and Rapoport, 2007). Diazepam,
an allosteric modulator of the GABAA receptor, both pre and
post-synaptically (site 4) (Polc et al., 1974; Sieghart, 1994), and
FIGURE 12 | Target sites for current and future antispastic treatments.
Pre-synaptic (1), motoneuron (2), muscle (3), and novel (4) sites for
antispastic treatments. Site 1: GABAB, NAα2, and 5-HT1 receptors (r)
located on pre-synaptic terminals or on interposed excitatory
interneurons can be activated by baclofen, tizanidine, and zolmitriptan,
respectively, to reduce excitatory glutamatergic release and activation of
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and
N-methyl-D-aspartate (NMDA) receptors located on the motoneurons. Site 2:
5-HT2 and NAα1 receptors on the motoneuron with constitutive or ligand
activation facilitate downstream voltage-gated calcium channels (CaV)
mediating PICs via Gq protein-coupled pathways. Inverse agonists, such as
cyproheptadine, switch the 5HT2 and NAα1 receptors to their inactive state,
reducing activity in the Gq pathway and lessening activation of PICs and
consequently muscle spasms. Site 3: Botulinum toxin (Botox®) injection
directly into spastic muscles or activation of ryanodine receptors by
dantrolene sodium (dantrolene) reduces spasticity by targeting the muscle
site directly. Site 4: Spinal injection of the HIV1-CMV-GAD65 lentivirus
increases GAD65 gene expression and GABA release from astrocytes.
Systemic administration of tiagabine, a GABA reuptake inhibitor, increases
amount of enhanced GABA in synapse to activate pre- and post-synaptic
GABA receptors to reduce motoneuron excitability. Activation of 5-HT2A
receptors increases cell expression of KCC2 cotransporter to reduce
intracellular concentration of Cl− and increase endogenous motoneuron
inhibition. Adapted from D’Amico et al. (2013a).
Frontiers in Integrative Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 36 | 15
D’Amico et al. Mechanisms of spasticity after SCI
gabapentin, a GABA analog with unknown mechanism of action
(Taylor, 1994; Sills, 2006) are also used as anti-spastics in SCI,
but as with most of the under-powered studies in SCI, there is no
quantitative evidence for a significant clinical effect (Taricco et al.,
2006).
The only currently used antispastic that directly affects the
excitability of the motoneuron (site 2, Figure 12) is cyprohep-
tadine (Nance, 1994; Gracies et al., 1997); however, it lacks
regulatory approval for this use. Cyproheptadine is as effec-
tive in reducing excessive muscle activity (17% reduction in
Ashworth scores) compared to clonidine (22%) and baclofen
(22%) (Nance, 1994), although this was only tested in 25 partic-
ipants. Associated with the anti-histamine and anti-cholinergic
properties of cyproheptadine were side effects such as CNS
depression, dry mouth, appetite stimulation and thus, the poten-
tial for weight gain (Gracies et al., 1997). Despite these side effects,
at low doses (12mg/day) cyproheptadine decreased involuntary
muscle spasms and clonus to improve residual walking function
in participants with incomplete SCI (Wainberg et al., 1990). The
development of more specific inverse agonists to 5-HT2/NAα1-
receptors with fewer side effects than cyproheptadine may lead
to better oral control of involuntary muscle spasms and clonus
in SCI.
Reduction of spasticity by directly targeting the muscle (site
3, Figure 12) is achieved with botulinum toxin injected into spe-
cific muscles and with oral dantrolene sodium (Satkunam, 2003).
Botulinum toxin, which blocks the release of acetylcholine at
the neuromuscular junction, allows a more localized reduction
in spasticity to injected muscles, but comes at the cost of fur-
ther reducing muscle strength (Das and Park, 1989a,b; Simpson,
2004). Botulinum toxin produced stable improvements in upper-
extremity function, hygiene and decreased pain in ∼65% of indi-
viduals with SCI (Marciniak et al., 2008). However, the duration
of effect is only 2–4 months, requiring repeated injections which
may further increase the amount of non-contractile tissue within
the target muscle (Fortuna et al., 2013). Dantrolene sodium is
an oral antispastic that affects the excitation-contraction cou-
pling in skeletal muscles by decreasing the release of calcium
from the sarcoplasmic reticulum through blocking the ryanodine
receptor (Britt, 1984; Krause et al., 2004; Lanner et al., 2010).
In individuals with SCI, dantrolene sodium effectively reduced
torque in response to passive stretch of the muscle (Herman et al.,
1972; Glass, 1974; Glass and Hannah, 1974; Meyler et al., 1981),
decreased reflex hyperexcitability and clonus and improvements
in activities of daily life (Meyler et al., 1981). While CNS depres-
sionmay occur with dantrolene sodium, it is less severe than other
oral antispastics (Watanabe, 2009; Lapeyre et al., 2010). Despite
the reduction in reflexes, dantrolene sodium is not commonly
prescribed for SCI spasticity likely because it produces general-
ized muscle weakness (Adams and Hicks, 2005) and can result in
hepatotoxicity (Gracies et al., 1997).
NEW AVENUES FOR PHARMACOLOGICAL AND GENE THERAPY
TREATMENTS
A common disadvantage of all oral treatments is their action on
supraspinal centers. Therefore, the ability to direct drug ther-
apies specifically to the spinal cord is very desirable. Recently,
a spinally targeted strategy was proposed by Marsala’s group
(site 4, Figure 12) where, in a rat model of ischemic SCI, the
efficacy of a GABA uptake inhibitor tiagabine, applied system-
ically, was increased while localizing its effects to the lumbar
spinal cord (Kakinohana et al., 2012). To do this, a lentivirus
applied to the lumbar spinal cord locally upregulated GAD65
gene expression in astrocytes. Because of the enhanced pro-
duction of GABA, the previously ineffective dose of tiagabine
was now able to reduce hindlimb stretch reflexes without pro-
ducing side effects such as CNS depression (Kakinohana et al.,
2012). The use of spinally-targeted gene therapies opens up
several different avenues for anti-spastic treatments with numer-
ous potential targets, such as the constitutively-active isoforms
of the 5-HT2C receptor or the KCC2 transporter. Despite the
promise of this strategy and its success in treating other disor-
ders such as Parkinson’s disease (Bjorklund et al., 2000; Kaplitt
et al., 2007) and blindness (Dinculescu et al., 2005; Buch et al.,
2008; Stieger et al., 2011), there are potential drawbacks to the use
of gene therapies including small packaging capacity, the risk of
insertional mutagenesis, immune responses against a vector and
difficulty in supplying sufficient concentrations of the selected
genes needed for human clinical trials (Monahan and Samulski,
2000). Thus, further research into this promising application is
needed.
As discussed above, novel targets for reducing spasticity,
such as the application of agonists to the 5-HT1B/F recep-
tors, like zolmitriptan, to reduce sensory transmission (site 1,
Figure 12) and 5-HT2A receptors to enhance KCC2 activity (site
4, Figure 12) are not suitable as oral antispastics due to their
potentially harmful effects at supraspinal and cardiovascular cen-
ters. However, if these agonists were delivered intrathecally to
the spinal cord, reductions in spasticity may be achieved over
the long-term. It would be worthwhile examining in animal
models of SCI if long-term use of intrathecal 5-HT1/2A ago-
nists is effective and if their symptoms of sudden withdrawal
are less severe than with baclofen. Additionally, it would be
worth testing the efficacy of intrathecal application of cypro-
heptadine which exerts its effects directly on the motoneuron
by reducing 5-HT2 and NAα1 receptor activity. Because cypro-
heptadine reduces the excitability of the motoneuron directly,
it may be used to treat spasticity for CNS disorders of varying
etiology, such as amyolateral sclerosis, multiple sclerosis, stroke,
traumatic brain injury and cerebral palsy. Better technologies for
intrathecal or spinal drug delivery will open possibilities for the
application of these newly discovered antispastics. However, as
discussed above, any agents that suppress spinal cord excitabil-
ity may further promote the compensatory changes within the
spinal cord that increases its excitability, such as increases in
constitutive monoamine receptor activity and sensory transmis-
sion and decreases in KCC2 activity. In fact, the development
of tolerance to antispastic drugs may, in part, be produced by
increasing these compensatory mechanisms by pharmacologi-
cal suppression of the spinal cord and muscle. Thus, strategies
which enhance functional synaptic activation of the spinal cord,
such as the physical treatments described below, may be the
best solution to curb hyperexcitabilty of the spinal cord after
injury.
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PHYSICAL TREATMENTS
Physical treatments can successfully reduce spasticity and they
avoid the negative side effects associated with pharmacological
treatments. The first line of prevention and treatment of spastic-
ity by physical treatments targets the maintenance of joint range
of motion through strategies such as stretching (Bovend’Eerdt
et al., 2008), range of motion exercises (Harvey et al., 2009a),
static weight bearing (Odeen and Knutsson, 1981), and pas-
sive cycling (Rayegani et al., 2011). All of these techniques
have produced significant reductions in measures of spasticity
such as the Ashworth score and the pendulum test. However,
these techniques have produced inconsistent results on range of
motion and there is sparse evidence regarding improvements
in motor function (Harvey et al., 2009b), though reductions
in co-contraction and improved gait from stretching have been
reported (Bovend’Eerdt et al., 2008). Physical treatments pro-
duced a reduction in atrophy-related changes in muscle architec-
ture (Willoughby et al., 2000), reduced passive stiffness (Guissard
and Duchateau, 2004), reduced Ia transmission as assessed by
Hmax/Mmax ratios (Guissard and Duchateau, 2004; Rayegani
et al., 2011) and normalization of motoneuronal excitability
as assessed by F-wave/M-wave ratios (Rayegani et al., 2011) to
potentially contribute to the observed reductions in spasticity.
In participants with incomplete SCI who can perform volun-
tary contractions, therapies initiated to improve motor function
can also reduce spasticity. For example, body-weight supported
treadmill training consistently reduces ankle clonus across vari-
ous studies, in addition to reducing flexor and extensor spasms
and co-contraction and increasing PAD2 (Gorassini et al., 2009;
Adams and Hicks, 2011; Manella and Field-Fote, 2013; Knikou
and Mummidisetty, 2014). These measures of spasticity are also
associated with improvements in motor control such as increases
in voluntary motor strength, walking speed, and self-reported
mobility. In a recent pilot study, resistance training at maximal
intensity also improved walking and balance with a trend to
decrease the modified Ashworth score (Jayaraman et al., 2013).
Other forms of therapy involving voluntary contractions include
neural facilitation, hippotherapy and hydrotherapy, and all have
resulted in reduced measures of spasticity (Hsieh et al., 2012).
For example, 10 weeks of hydrotherapy (3×’s per week), in addi-
tion to passive range of motion exercises, significantly decreased
the Ashworth and Penn spasm frequency scores and resulted in
a significant decrease in the dosage of oral baclofen taken com-
pared to passive exercises alone (Kesiktas et al., 2004). Increases
in the strength of spared corticospinal pathways have also been
produced from physical treatments that incorporate voluntary
contractions, such as treadmill training (Thomas and Gorassini,
2005). Thus, reductions in spasticity from these active physical
treatments that provide functional, patterned synaptic activation
of the spinal cord may result from enhanced activation of spinal
inhibitory circuitry by strengthened descending motor pathways
(Zewdie et al., 2011) and/or from decreases in sensory transmis-
sion by enhanced activation of the dorsal horn by descending
monoaminergic pathways (Murray et al., 2011b; Rank et al.,
2011). In addition, the increased activation of the spinal cord
by synaptic inputs during active treatments may increase spinal
BDNF to facilitate KCC2 activity and subsequently, intrinsic
motoneuron inhibition (Gomez-Pinilla et al., 2007; Boulenguez
et al., 2010).
Electrical stimulation of the spinal cord, peripheral nerves
and muscles has also been used to treat spasticity and/or motor
impairment. A single session of stimulation that results in muscle
contractions consistently demonstrates acute reductions in spas-
ticity, which is thought to be mediated by muscle fatigue induced
from electrically-elicited contractions (Marsolais and Kobetic,
1988). For example, stimulation of the triceps surae generating
isometric contractions decreased themodified Ashworth score for
the plantarflexors (Van Der Salm et al., 2006). Similarly, func-
tional electrical stimulation (FES)-assisted cycling also decreased
the modified Ashworth score and pendulum test in people
with complete SCI (Krause et al., 2008). It has been theorized
that long-term stimulation which increases muscle hypertrophy
(Skold et al., 2002) and strength (Granat et al., 1993) could be
associated with increases in spasm strength. However, research
has failed to consistently confirm that long-term stimulation pro-
tocols adversely impact spasticity. In contrast, an 8 week program
of stimulation of the quadriceps and hamstrings that produced
subtetanic isometric contractions reduced spasms as measured
by SCATs in people with motor complete SCI (Carty et al.,
2013). Similarly people with incomplete SCI who used FES to
augment gait training for at least 16 months had decreased intrin-
sic and reflex stiffness (Mirbagheri et al., 2002). Moreover, 15
days of tibial nerve stimulation that did not result in perceptible
contractions reduced Ashworth scores, spasm frequency, tendon
and H-reflex to a similar extent as oral baclofen (Aydin et al.,
2005). Although most studies show improvements in spasticity
with long-term electrical stimulation, some individuals did rank
their spasticity as worse following 6 months of FES cycling, even
though there were no changes in their modified Ashworth Scores
(Skold et al., 2002). More invasive modes of stimulation, such
as spinal cord stimulation with epidural electrodes, improved
resistance to passive stretch and reduced the use of antispastic
medications (Pinter et al., 2000). However, some negative side
effects with a previous epidural stimulator included loss of effec-
tiveness and stimulator failure over ∼10 year period (Midha and
Schmitt, 1998) and suggest, like intrathecal drug delivery, some
technical issues need improvement before more invasive methods
of treating spasticity become mainstream.
COMBINED EXCITATORY PHARMACOLOGICAL AND PHYSICAL
TREATMENTS
An alternative method to reduce spasticity may be to first increase
the functional activation of the spinal cord by residual descending
and intact peripheral synaptic inputs. This would then increase
control over excitatory circuits and enhance the activation of
intrinsic inhibitory mechanisms (KCC2) to curb involuntary,
intrinsic (PIC) activation of motoneurons. Recently, combined
excitatory pharmacological and physical treatments have been
used in both animals and humans to increase spinal cord
excitability and promote the recovery of walking function. In par-
ticipants with incomplete SCI, treadmill training was combined
with the oral administration of escitalopram, a selective serotonin
reuptake blocker, to increase the amount of serotonin released
in the spinal cord (Hornby et al., 2009). Elevation in serotonin
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levels would potentially increase the excitability of motoneu-
rons via 5-HT2B/C receptors (Murray et al., 2011a), increase the
excitability of locomotor interneurons via 5-HT1A, 5-HT7, and
5-HT2A/C receptors (Courtine et al., 2009; Jordan and Slawinska,
2011; Slawinska et al., 2013) and decrease transmission of sensory
inputs via 5-HT1B/F receptors (Murray et al., 2011b). When com-
bined with 8 weeks of treadmill training, escitalopram produced
a greater improvement in walking function (maximum speed)
when compared to participants receiving treadmill training alone
(Hornby et al., 2009). Likewise, a combination of spinal cord
stimulation and intrathecal application of 5-HT1A, 5-HT7, and
5-HT2A receptor agonists improved volitional control of walking
in a rat model of incomplete SCI (Van Den Brand et al., 2012). In
the human study, although walking performance improved with
increases in 5-HT receptor activation, measures of spasticity also
increased (Thompson et al., 2011; Thompson andHornby, 2013),
likely due to the facilitation of 5-HT2B/C receptors. It remains
to be seen if, over time, motor training can better shape the
enhanced activation of the spinal cord by descending and periph-
eral inputs to improve control of spasticity when excitability of the
spinal cord is increased pharmacologically. Perhaps application of
5-HT receptor agonists that specifically target locomotor-related
interneurons (e.g., 5-HT1A, 5-HT7, and 5-HT2A) over motoneu-
rons (5-HT2B/C) may produce greater improvements in walking
function with fewer increases in spastic motor behaviors.
CONCLUSIONS
Following the reduction of synaptic excitation by descending
and movement-related sensory inputs, the spinal cord below the
injury adapts by increasing the intrinsic excitability of motoneu-
rons via increases in constitutive monoamine receptors and
downregulation of KCC2, resulting in uncontrolled activation
of muscles below the injury. Strategies to help improve con-
trolled and functional activation of motoneurons via synaptic
inputs may help to strengthen the purposeful activation of mus-
cles and reduce the involuntary activation of motoneurons by
suppressing some of these maladaptive changes. For example,
enhanced descending and/or sensory activation of motoneurons
during facilitated motor tasks, such as treadmill or exoskeleton
walking, FES-assisted cycling or rowing, which can be applied
to participants with motor complete or incomplete injuries, may
produce enough pattered activation of motoneurons to help
curb, in an activity dependent manner, increases in constitutive
monoamine receptor activity and/or promote BDNF-facilitation
of KCC2 activity (Boulenguez et al., 2010). Thus, rather than sup-
pressing the involuntary activation of motoneurons and muscles
with suppressive pharmacology, perhaps we should be exciting
the spinal cord with functional, patterned activity that occurs,
or mimics, inputs produced during natural movement to keep
intrinsic, inhibitory mechanisms viable. Despite the numerous
and effective physical strategies to improve motor function and
treat spasticity, individuals with SCI are typically prescribed phar-
macological interventions that reduce spinal cord excitability as
the first line of treatment (Rekand et al., 2012). Further studies
comparing the effectiveness of physical, vs. suppressive pharma-
cological, treatments over the long-term are needed to determine
the best approach for treating and managing spasticity after SCI.
The best approach to control spasticity and improve residual
motor function may be to increase the activation of the spinal
cord with functional, patterned inputs akin to what happens dur-
ing natural movements such as walking and reaching. This may
improve both descending and peripheral control over excitatory
spinal circuits and enhance intrinsic inhibition in the spinal cord
to reduce spasticity.
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